Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 99,652 | 141,209 | 106,140 | 101,418 | 112,512 |
| Depreciation Amortization | -3,213 | -9,602 | -6,766 | 4,829 | 8,559 |
| Income taxes - deferred | -37,537 | -40,191 | -29,493 | -33,905 | 4,346 |
| Accounts receivable | -5,810 | -12,853 | -10,066 | -3,432 | -1,427 |
| Accounts payable and accrued liabilities | 25,068 | -2,020 | 5,420 | 4,757 | -3,597 |
| Other Working Capital | -1,406 | 45,525 | 7,860 | 5,539 | -466 |
| Other Operating Activity | 65,242 | 76,227 | 53,586 | 41,117 | 47,965 |
| Operating Cash Flow | $141,996 | $198,295 | $126,681 | $120,323 | $167,892 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -319,607 | -588,310 | -328,748 | -355,066 | 136,595 |
| PPE Investments | -211 | -2,172 | -139 | -413 | -469 |
| Purchase Of Investment | 389,576 | 412,878 | 419,793 | 241,152 | N/A |
| Investing Cash Flow | $69,758 | $-177,604 | $90,906 | $-114,327 | $136,126 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 25,490 | 9,616 | 5,811 | 4,381 | 16,229 |
| Common Stock Repurchased | -172,915 | -15,664 | -145,428 | N/A | -295,985 |
| Other Financing Activity | -72,941 | -22,301 | -9,106 | -21,665 | -22,835 |
| Financing Cash Flow | $-220,366 | $-28,349 | $-148,723 | $-17,284 | $-302,591 |
| Exchange Rate Effect | 1,442 | -228 | 358 | N/A | N/A |
| Beginning Cash Position | 127,665 | 135,551 | 66,329 | 77,617 | 76,190 |
| End Cash Position | 120,495 | 127,665 | 135,551 | 66,329 | 77,617 |
| Net Cash Flow | $-7,170 | $-7,886 | $69,222 | $-11,288 | $1,427 |
| Free Cash Flow | |||||
| Operating Cash Flow | 141,996 | 198,295 | 126,681 | 120,323 | 167,892 |
| Capital Expenditure | -211 | -2,172 | -139 | -413 | -469 |
| Free Cash Flow | 141,785 | 196,123 | 126,542 | 119,910 | 167,423 |